Reply to: Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment

Carl-Jacob Holmberg; Lisanne P. Zijlker; Dimitrios Katsarelias; Anne E. Huibers; Michel W. J. M. Wouters; Yvonne Schrage; Sophie J. M. Reijers; Johannes V. van Thienen; Dirk J. Grünhagen; Anna Martner; Jonas A. Nilsson; Alexander C. J. van Akkooi; Lars Ny; Winan J. van Houdt; Roger Olofsson Bagge

doi:10.1016/j.ejso.2024.108653

Reply to: Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment

Carl-Jacob Holmberg
, Lisanne P. Zijlker
, Dimitrios Katsarelias
, Anne E. Huibers
, Michel W. J. M. Wouters
, Yvonne Schrage
, Sophie J. M. Reijers
, Johannes V. van Thienen
, Dirk J. Grünhagen
, Anna Martner
, Jonas A. Nilsson
, Alexander C. J. van Akkooi
, Lars Ny
, Winan J. van Houdt
, Roger Olofsson Bagge^*

^*Corresponding author for this work

Sahlgrenska University Hospital
University of Gothenburg
Netherlands Cancer Institute
Melanoma Institute Australia
Erasmus University Rotterdam
The Harry Perkins Institute of Medical Research
The University of Sydney
Royal Prince Alfred Hospital

Research output: Contribution to journal › Comment/Letter to the editor › Academic

10 Downloads (Pure)

Original language	English
Article number	108653
Journal	European journal of surgical oncology
Volume	50
Issue number	12
DOIs	https://doi.org/10.1016/j.ejso.2024.108653
Publication status	Published - 1 Dec 2024
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.ejso.2024.108653

Reply-to.pdfFinal published version, 294 KBLicence: Taverne

Cite this

Holmberg, C.-J., Zijlker, L. P., Katsarelias, D., Huibers, A. E., Wouters, M. W. J. M., Schrage, Y., Reijers, S. J. M., van Thienen, J. V., Grünhagen, D. J., Martner, A., Nilsson, J. A., van Akkooi, A. C. J., Ny, L., van Houdt, W. J., & Olofsson Bagge, R. (2024). Reply to: Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment. European journal of surgical oncology, 50(12), Article 108653. https://doi.org/10.1016/j.ejso.2024.108653

@article{0fb946d3954841588db8f5650a48b9b0,

title = "Reply to: Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment",

author = "Carl-Jacob Holmberg and Zijlker, \{Lisanne P.\} and Dimitrios Katsarelias and Huibers, \{Anne E.\} and Wouters, \{Michel W. J. M.\} and Yvonne Schrage and Reijers, \{Sophie J. M.\} and \{van Thienen\}, \{Johannes V.\} and Gr{\"u}nhagen, \{Dirk J.\} and Anna Martner and Nilsson, \{Jonas A.\} and \{van Akkooi\}, \{Alexander C. J.\} and Lars Ny and \{van Houdt\}, \{Winan J.\} and \{Olofsson Bagge\}, Roger",

year = "2024",

month = dec,

day = "1",

doi = "10.1016/j.ejso.2024.108653",

language = "English",

volume = "50",

journal = "European journal of surgical oncology",

issn = "0748-7983",

publisher = "W.B. Saunders Ltd",

number = "12",

}

Holmberg, C-J, Zijlker, LP, Katsarelias, D, Huibers, AE, Wouters, MWJM, Schrage, Y, Reijers, SJM, van Thienen, JV, Grünhagen, DJ, Martner, A, Nilsson, JA, van Akkooi, ACJ, Ny, L, van Houdt, WJ & Olofsson Bagge, R 2024, 'Reply to: Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment', European journal of surgical oncology, vol. 50, no. 12, 108653. https://doi.org/10.1016/j.ejso.2024.108653

TY - JOUR

T1 - Reply to

T2 - Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment

AU - Holmberg, Carl-Jacob

AU - Zijlker, Lisanne P.

AU - Katsarelias, Dimitrios

AU - Huibers, Anne E.

AU - Wouters, Michel W. J. M.

AU - Schrage, Yvonne

AU - Reijers, Sophie J. M.

AU - van Thienen, Johannes V.

AU - Grünhagen, Dirk J.

AU - Martner, Anna

AU - Nilsson, Jonas A.

AU - van Akkooi, Alexander C. J.

AU - Ny, Lars

AU - van Houdt, Winan J.

AU - Olofsson Bagge, Roger

PY - 2024/12/1

Y1 - 2024/12/1

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85204699235&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/39266404

U2 - 10.1016/j.ejso.2024.108653

DO - 10.1016/j.ejso.2024.108653

M3 - Comment/Letter to the editor

C2 - 39266404

SN - 0748-7983

VL - 50

JO - European journal of surgical oncology

JF - European journal of surgical oncology

IS - 12

M1 - 108653

ER -

Reply to: Pioneering combination: Nivolumab and isolated limb perfusion in melanoma in-transit metastases treatment

UN SDGs

Access to Document

Other files and links

Cite this